CLGN

NASDAQ · Biotechnology

Collplant Biotechnologies Lt

Penny Stocks Biotech Stocks Healthcare Stocks

$0.33

+0.01 (+3.48%)

As of Aug 15, 2:35 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +5,113.8% upside

Low Target $14.35

Average Target $17.19

High Target $29.92

Current Price $0.33

Current
$0.33

Target
$17.19

$14.35 $17.19 avg $29.92

Scenario Analysis

Bear Case

$14.35

4,252.4%

Low target

Base Case

$17.19

+5,113.8%

Avg target

Bull Case

$29.92

+8,974.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$3.18

-89.6% from high

52-Week Low

$0.27

+22.2% from low

Target vs 52W High

$17.19

+440.6% vs high

Next Earnings Report

Aug 20, 2026

until earnings

EPS Est: $0.06

Earnings in 4 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%